FR4630M - - Google Patents

Info

Publication number
FR4630M
FR4630M FR19961A FR19961A FR4630M FR 4630 M FR4630 M FR 4630M FR 19961 A FR19961 A FR 19961A FR 19961 A FR19961 A FR 19961A FR 4630 M FR4630 M FR 4630M
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR19961A
Other languages
French (fr)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to FR19961A priority Critical patent/FR4630M/fr
Application granted granted Critical
Publication of FR4630M publication Critical patent/FR4630M/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
    • C07D339/02—Five-membered rings
    • C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
FR19961A 1965-06-09 1965-06-09 Expired FR4630M (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR19961A FR4630M (zh) 1965-06-09 1965-06-09

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR19961A FR4630M (zh) 1965-06-09 1965-06-09

Publications (1)

Publication Number Publication Date
FR4630M true FR4630M (zh) 1966-11-28

Family

ID=8581227

Family Applications (1)

Application Number Title Priority Date Filing Date
FR19961A Expired FR4630M (zh) 1965-06-09 1965-06-09

Country Status (1)

Country Link
FR (1) FR4630M (zh)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318891A1 (de) * 1987-12-04 1989-06-07 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
EP0702953A2 (de) 1994-09-22 1996-03-27 ASTA Medica Aktiengesellschaft Darreichungsformen enthaltend Thioctsäure, oder feste Salze von Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
WO1999055331A1 (de) * 1998-04-25 1999-11-04 Skw Trostberg Aktiengesellschaft Verwendung von alpha-liponsäure zur verringerung des appetits und/oder zur körpergewichtsreduzierung
WO2000053176A1 (en) * 1999-03-05 2000-09-14 Uni-Ci S.R.L. Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine
FR2791571A1 (fr) * 1999-04-02 2000-10-06 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
WO2001085165A2 (de) * 2000-05-10 2001-11-15 Basf Aktiengesellschaft Kombination von liponsäure und c1-donoren zur behandlung von störungen des zentralen nervensystems
WO2002030918A2 (en) * 2000-10-10 2002-04-18 Laboratorio Chimico Internazionale S.P.A. PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID
WO2003099806A1 (en) * 2002-05-27 2003-12-04 Licrea S.R.L. Creatine salt having enhanced nutritional, antioxidant and therapeutic efficacy and compositions containing same
CN104387364A (zh) * 2014-12-15 2015-03-04 南京工业大学 L-鸟氨酸硫辛酸复合盐及其制备方法和应用

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0318891A1 (de) * 1987-12-04 1989-06-07 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
EP0702953A2 (de) 1994-09-22 1996-03-27 ASTA Medica Aktiengesellschaft Darreichungsformen enthaltend Thioctsäure, oder feste Salze von Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
WO1999055331A1 (de) * 1998-04-25 1999-11-04 Skw Trostberg Aktiengesellschaft Verwendung von alpha-liponsäure zur verringerung des appetits und/oder zur körpergewichtsreduzierung
WO2000053176A1 (en) * 1999-03-05 2000-09-14 Uni-Ci S.R.L. Pharmaceutic, dietetic and cosmetic compositions based on thioctic acid and cysteine
WO2000059448A3 (fr) * 1999-04-02 2001-03-08 Sod Conseils Rech Applic Association d'inhibiteur(s) de no synthase et d'antioxydant(s) metabolique(s)
WO2000059448A2 (fr) * 1999-04-02 2000-10-12 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Association d'inhibiteur(s) de no synthase et d'antioxydant(s) metabolique(s)
FR2791571A1 (fr) * 1999-04-02 2000-10-06 Sod Conseils Rech Applic Association inhibiteur(s) de no synthase et antioxydant(s) metabolique(s)
WO2001085165A2 (de) * 2000-05-10 2001-11-15 Basf Aktiengesellschaft Kombination von liponsäure und c1-donoren zur behandlung von störungen des zentralen nervensystems
WO2001085165A3 (de) * 2000-05-10 2002-05-02 Basf Ag Kombination von liponsäure und c1-donoren zur behandlung von störungen des zentralen nervensystems
WO2002030918A2 (en) * 2000-10-10 2002-04-18 Laboratorio Chimico Internazionale S.P.A. PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID
WO2002030918A3 (en) * 2000-10-10 2002-08-01 Laboratorio Chimico Int Spa PROCESS FOR THE PRODUCTION OF R(+)α-LIPOIC ACID
WO2003099806A1 (en) * 2002-05-27 2003-12-04 Licrea S.R.L. Creatine salt having enhanced nutritional, antioxidant and therapeutic efficacy and compositions containing same
CN104387364A (zh) * 2014-12-15 2015-03-04 南京工业大学 L-鸟氨酸硫辛酸复合盐及其制备方法和应用

Similar Documents

Publication Publication Date Title
FR4630M (zh)
JPS429400Y1 (zh)
BE675324A (zh)
FR4512M (zh)
JPS4410286Y1 (zh)
JPS427677Y1 (zh)
JPS42591Y1 (zh)
JPS4030092Y1 (zh)
JPS4428258Y1 (zh)
BE673418A (zh)
BE675750A (zh)
BE675742A (zh)
BE675747A (zh)
BE704635A (zh)
BE675322A (zh)
BE675243A (zh)
BE674974A (zh)
BE674971A (zh)
BE674821A (zh)
BE674783A (zh)
BE674536A (zh)
BE673838A (zh)
BE673690A (zh)
BE673583A (zh)
BE672974A (zh)